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esponsibility of Xi’Abstract Otamixaban is a potent (Ki¼0.5 nM) fXa inhibitor currently in late-stage clinical develop-
ment at Sanoﬁ for the management of acute coronary syndrome. Being unproductive in obtaining a
suitable crystal of Otamixaban, the required enantiomeric characterization has been accomplished using
vibrational circular dichroism (VCD) spectroscopy. Selected by a spectrum similarity index, the calculated
spectra of several higher energy conformers were found to match well with the observed spectra. The
characteristic IR bands of these conformers were also identiﬁed and attributed to the solvation effect.
Combined with both the single crystal x-ray diffraction results for an intermediate and the proton NMR
study, the absolute conﬁguration of Otamixaban is unambiguously determined to be (R,R).
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As a potent (Ki¼0.5 nM) and selective Factor Xa (fXa) inhibitor,
Otamixaban is in late-stage clinical development for the management
of acute coronary syndrome [1]. Although its stereochemistry was
established from the co-crystal structure with fXa [2], the absolute
conﬁguration (AC) of Otamixaban from a different synthetic route
needs to be veriﬁed for both the regulatory requirement and quality
control. The task is usually handled by the single crystal x-ray
diffraction (scXRD) method [3]. However, our effort to obtain a
suitable crystal of Otamixaban was unsuccessful. Since vibrational
circular dichroism (VCD) spectroscopy [4–7] is an alternative methodier B.V. All rights reserved.
J. Shen et al.198of AC determination, we attempted to explore this approach for
Otamixaban.
The VCD method is based on the model-observation agreement.
When a simulated spectrum of a model matches the experimental
spectrum of a sample, the AC of the model is assigned to the
sample. The challenges in Otamixaban AC determination are
mainly due to the molecular size and ﬂexibility, which affect both
the modeling and experiment. With nine rotational bonds and a
molecular weight of 446, Otamixaban is larger and more ﬂexible
than most molecules in published VCD studies [8–10]. To
simplify the spectrum simulation of large molecules, Dunmire
et al. [11] replaced ketoconzole using two small chiral fragments,
of 308 and 304 molecular weight. This approximation, however, is
not suitable for Otamixaban because its two chiral centers are
directly bonded. While today's computing power is capable of the
spectrum calculation for the whole Otamixaban, handling the sheer
volume of spectrum comparisons and providing the convincing
evidence of AC are not trivial.
On the VCD experiment of large and ﬂexible chiral molecules,
the band broadening and low signal-to-noise ratio (S/N) were
frequently observed due to an increasingly larger number of
fundamentals in the VCD sensitive region (1100–1500 cm1)
and multiple populated conformers. As a result, a fewer band-to-
band matches can be established between a model and observed
spectrum. Because both the conformation and conﬁguration can
affect the number and sign of VCD bands, an AC assignment for
such a molecule is often questionable without an error estimating.
To overcome the difﬁculties in the manual spectrum compar-
ison, we [12] developed a VCD spectrum similarity index, SV,
which has been used to select the best matched spectra from
calculations. We further discovered that the SV of unmatched
spectra has a normal distribution with a mean value of 0 and a
standard deviation of 0.1 [13]. This statistical characteristic canNH2
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Scheme 1 Synthesis robe used to eliminate wrong models and to provide a conﬁdence
estimate for an assigned AC. We used the same approach herein
for Otamixaban. To provide an unbiased assessment, we assumed
no prior knowledge about the chirality of the sample thereby
investigating all possible conﬁgurations. In addition, IR and NMR
were used to study the solution conformations of Otamixaban.2. Experiment
2.1. Reagents and chemicals
The Otamixaban sample was prepared in our lab through the
synthetic route described in Scheme 1.
2.2. IR and VCD data collection and processing
The experimentally observed IR and VCD spectra (4.6 mg
Otamixaban dissolved in 0.15 mL DMSO-d6) were measured by
Biotools using ChiralIR-2X with Dual Pem. The spectra were
acquired at the resolution of 4 cm1 for 10 h with a path length of
100 μm. The solvent signal was subtracted from both spectra. The
measured VCD spectra were corrected for baseline artifacts by
subtracting the enantiomer spectra [10]. The conformation search
was carried out using Maestro 8.5 (Schrödinger, LLC). In order to
save computing resources and to identity the AC quickly, a coarse
sampling with an energy cutoff of 5 kcal/mol (20.934 kJ/mol) and
an RMSD of 2 Å were used to generate starting conformers for the
subsequent density functional theory (DFT) calculations. After
eliminating the unmatched stereoisomer, conformation searches
with smaller RMSD of 0.5 Å were used to generate additional
conformers. Similar to other studies [12,13], Gaussian 03 (Gaussian
Inc.) [14] with 6-31G(d) basis set and PBEPBE functional wereNH
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Otamixaban
nobenzylbromide; iii. benzoic acid, water/toluene; b) i. aq.
 c) MMPP, CH 2Cl2/H2O; d) i. HCl/MeOH; ii. N H3.
2H
ute of Otamixaban.
Fig. 1 scXRD structure of Otamixaban intermediate 4. (A) Mole-
cular structure, atomic numbering scheme and thermal ellipsoids
(20%) of the determined molecule; (B) part of the inﬁnite three-
dimensional framework; projection nearly along the crystallographic
b-axis; hydrogen bonds are given as red and light blue lines; (C) stick
models of 4 (orange) and Otamixaban (cyan) in PDB1KNS.
Vibrational circular dichroism of Otamixaban 199used for DFT optimization and spectrum calculations. A Lorentzian
half-width of 12 cm1 was used to generate the calculated spectra.
The spectrum comparison and alignment were carried out using
the SimIR/VCD [12] protocol implemented in Scitegic Pipeline-
Pilot 8.0 (Accerys Inc.). Brieﬂy, the two similarities between
calculated (c) and observed (o) IR and VCD spectra, respectively,
are deﬁned as
SI ¼
Ico
Iccþ Ioo Ico ð1Þ
SV ¼
Ico
Iccþ IoojIcoj ð2Þ
I
ij ¼
R
FiðvÞFjðvÞ dv ð3Þ
where Iij are the self and overlap integrals of spectra i and j.
The sign of SV indicates whether the model and the sample have
the same AC (þ) or they are an enantiomeric pair ( ). The SI and
SV were either computed directly or optimized in the following
procedure. First, the calculated IR spectrum was divided into a
number of bands. Each band was then shifted locally to maximize
SI. These optimized shifts were then applied to the calculated VCD
spectrum yielding an optimized SV. For comparison and plotting,
the strengths of the measured and calculated spectra were scaled
to 0–1 and 1 to 1 for IR and VCD spectra respectively. For
conformation averaging, the multiple calculated IR and VCD
spectra were added together with the corresponding population
weight, and then treated as single spectra in the procedure.
2.3. NMR
The 1H spectra were acquired for an Otamixaban sample
(4.5 mg dissolved in 0.7 mL of DMSO-d6) on a Varian INOVA
600 MHz NMR spectrometer equipped with a 5-mm cyro-probe.
A spectral width of 6225 Hz was used with 16 transients and 8 k
data points. The FIDs were zero-ﬁlled to 16 k to give a spectral
resolution of 0.75 Hz/point. The calculated coupling constants
were obtained using MSpin V1.2.1-49 (MestReLab Research S.L)
with the Karplus equation [15]
3J ¼ Aþ B cos ϕþ C cos 2ϕ ð4Þ
where ϕ is the dihedral angle with constants A, B and C being 7,
1 and 5, respectively.
2.4. scXRD
Crystallization trials on 4, the last intermediate of Otamixaban,
were executed. One of these trials yielded a crystal (0.5 mm 
0.08 mm 0.04 mm in size) which was investigated on a Bruker/
AXS three circle diffractometer, equipped with a SMART APEX
area-detector and a copper-Kα microfocus generator. Data frames
were collected using the program package SMART V 5.628
(Bruker AXS, 2001) applying ω-scans with step widths of
0.51 and an exposure time of 20 s. Data processing yielded 7624
reﬂections (ϑmin¼2.78, ϑmax¼69.20; 31oho31, 5oko4,
19olo19) of which 3080 reﬂections were unique (Rint¼
0.0219, Rs¼0.0273). The positions of all H atoms were experi-
mentally determined from a difference Fourier synthesis map,
except those bonded to the methoxy group, which were calculated,
Sgoodness of ﬁt¼1.028, Rall data¼0.0366 (Robs. data¼0.0309 for 2722
reﬂections with |Fobs|44s, wR2all data¼0.0827, wR2obs. data¼0.0792).3. Results and discussions
3.1. scXRD
The single crystal structure of intermediate 4 is determined as
shown in Fig. 1A. The structure contains disordered oxygen atoms
within the carboxyl methyl group with split positions for O01
(O011) and O02 (O021). The site occupancy factors for the
disordered atoms were reﬁned to 0.50 for all disordered oxygen
atoms (O01, O011, O02, O021). Each molecule in the crystal has
two H-bonds (3.072 Å) which connect two neighboring molecules
through the amide moiety and form one-dimensional arrays along
J. Shen et al.200the crystallographic b-axis (Fig. 1B). The molecules in each array
are closely packed with no space for solvent. There is no
observable interaction among the arrays. The overall conformation
of the structure is very similar to that of Otamixaban bound to fXa
(1 KSN, the ligand was synthesized with a different route) except
for the rotation of the 3-phenyl ring as shown in Fig. 1C. The
determination of two (R) conﬁgured chiral centers agrees with the
previously determined structure of the intermediate 2 and supports
the conclusion that no change of the stereochemistry occurs during
the two synthesis steps from 2 to 4. While this implies a (R,R)
conﬁguration of the ﬁnal product, the direct evidence for the
Otamixaban's AC is provided by the following VCD investigation.
3.2. VCD
The experimentally observed VCD spectrum shown in Fig. 2 is
not ideal for a straight-forward IR-VCD band-to-band matching.
The low signal-to-noise ratio (S/N) gives only a few signiﬁcant
bands as labeled in the VCD spectrum. Among them, bands at
1348.1 cm1 and 1301.8 cm1 appear in a better S/N frequency
region. However, their corresponding IR bands are very weak,
which makes the IR spectrum less useful for identifying the
matching VCD bands in the calculated spectra. It is worth noting
that the lower S/N is not unusual as we have seen in other cases of
ﬂexible molecules. Although varying experiment conditions might
improve the S/N somewhat, the band broadening with reduced
signal strength is intrinsic for ﬂexible molecules due to the
existence of multiple populated conformations.
The qualitative match between the models and experiment was
achieved by statistical analysis; all calculated SV are shown in17
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Fig. 2 Observed IR (bottom, left axis), VCD and noise (middle and
top with zero baselines, right axis) spectra of Otamixaban in DMSO-d6.
The noise spectrum is up-shifted to 1.5 for clarity.Fig. 3. As Otamixaban has two chiral centers, both (R,R) and (S,R)
stereoisomers were modeled to explore all four possibilities
including (S,S) and (R,S). The SV of (S,R) conformers has a
Gaussian-like distribution centered at 0.04 with a standard devia-
tion (SD) of 0.09. No |SV| was found greater than 0.2 in this group.
These characters are similar to those of spectrum-unﬁt (SU)
conformers [13], which implies that (S,R) or (R,S) is not the AC
of the sample.
In contrast, the SV distribution of (R,R) conformers signiﬁcantly
shifts away from zero, with a mean value of 0.14 and an SD of 0.1,
which is a sign of spectrum-ﬁt (SF) conformers [13]. Among the
(R,R) conformers, three are of a higher |SV| exceeding 0.2,
indicating they are likely to be the SF conformers. The VCD
spectra of four high SV conformers (RR2, RR5, RR10, and RR13)
were individually aligned with the observed spectrum shown in
Fig. 4. The resemblance between the observation and the
simulated spectra is apparent. The corresponding values of SI,
and optimized SV in Table 1 are in the range for matched spectra.
The previous study [13] suggests that properly averaged spectra
of SF conformers should yield better agreement with the observa-
tion. Indeed, the averaging of the above four spectra improved the
optimized SV to 0.42, which is signiﬁcantly higher than those of
individual spectra. Apparently, the averaged spectrum, 〈RR〉, in
Fig. 4 resembles the observation better than any individual one.
For the averaged IR spectrum, the band at 1525 cm1 appears
corresponding to the observed band at 1540 cm1. There is no
observed band corresponding to the calculated band at 1360 cm1.
Given the approximations in calculation and the size and ﬂexibility
of the molecule, the calculated spectrum agrees reasonably well
with the observed one.
The quantitative AC assessment of Otamixaban is based on the
value of optimized SV [13]. The positive sign of SV indicates that
the 〈RR〉 model and the sample are of the same AC. The absolute
value of SV (0.42) is about four times the SD (0.1). Accordingly,
the (R,R) assignment of Otamixaban has a conﬁdence level greater
than 99.8%. This assignment is consistent with the expectation and
the scXRD structure of the ﬁnal intermediate 4.
While a VCD spectrum associated with the lowest energy
conformer often closely resembles the observed one or weights
substantially in conformational averaging, we found this is not the
case for Otamixaban. The similarity between the observed
spectrum and that of the lowest energy conformer (RR1) is very
low with an SV of 0.09 as shown in Fig. 4 and Table 1. An
independent AC conﬁdence assessment using the CompareVOA
program [16] for RR1 gave only 52%, much lower than 86% for
RR5. Including the RR1 spectrum in averaging with various
weights lowered the averaged SV, indicating that RR1 is not an
SF conformer. Obviously, despite its lower energy, RR1 is not
signiﬁcantly populated in the sample based on the spectrum
ﬁtness.
We further found that the lower energy of RR1 is caused by an
intramolecular H-bond between the amide oxygen and one of
benzamidine nitrogen (dO–N¼3.02 Å). This H-bond also exists in
RR2 (dO–N¼3.03 Å), the second lowest energy conformer, but not
in the other three conformers (see Fig. 5). It is well known that
polar solvents can weaken intramolecular H-bonds. Although this
could explain the mismatch of the RR1 spectrum, we speculated as
to whether or not higher energy SF conformers such as RR5 could
be detected by other experiments.
The presence of non-H-bond conformers is evident in the 1650–
1750 cm1 region of the IR spectrum, which has three major
absorption bands corresponding to the NH2 bending (fundamental
Fig. 3 The distribution of SV for RR and SR conformers.
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Fig. 4 The ligned VCD (top 6) and IR spectra of Otamixaban
conformers with blue for the experiment and red for the calculation.
Vibrational circular dichroism of Otamixaban 201143), the C¼O stretching of the amide (fundamental 144) and the
C¼O stretching of the ester (fundamental 145) (see Table 2). For
RR1 and RR2, the former two bands are separated by less than
10 cm1 thereby merging into one band in the simulated spectra.
In contrast, the IR spectrum of RR5 clearly shows the three
distinct bands, which matches the experiment very well. The
frequency of fundamental 144 of RR5 is 16–17 cm1 higher thanthose of RR1 and RR2. This high frequency shift is also observed
in the calculated IR spectra of RR10 and RR13. Both conformers
lack the intramolecular H-bond. The C¼O band shift in DMSO
has been well documented and is attributed to the weakening of
the intramolecular H-bond by DMSO-d6 [17].3.3. NMR
A common feature of the four SF conformers is their folded
conformations with relatively smaller solvent assessable surface
area compared with that of the two x-ray structures, shown in
Table 1. This seems associated with the values of torsion angle
connecting the chiral centers. Is the conformation difference
between VCD and x-ray conformers due to the polarity of
solvents? In order to answer this question, 1H NMR was applied
to the same sample. While the technique cannot detect individual
conformation, it can provide information for an averaged torsion
angle by measuring the vicinal proton–proton coupling constant
(3JHH).
We investigated the torsion associated with the two protons, Ha
and Hb, attached to the two chiral carbons. The full
1H NMR
spectrum and detailed chemical shifts in Fig. 6 show that 3JHaHb
increases from 5.8 in pure DMSO-d6 up to 6.4 with 6% of D2O
added. The calculated 3JHaHb values of the four SF conformers
shown in Table 1 agree well with the observed value in pure
DMSO-d6. In contrast, the calculated
3JHaHb values of the two
x-ray conformers closely match the value observed in DMSO-d6
with 6% D2O. Although the empirical prediction depends on a
particular set of parameters and can have statistical errors [18], the
conformation shifting from pure DMSO-d6 to more polar water-
containing solvent has been conﬁrmed. The solvation not only
explains the conformation difference between the VCD confor-
mers and x-ray conformers, but also answers why RR1 is not
populated in the sample despite its lowest energy from the gas
phase calculation.
3.4. Conformer population
The unﬁt of RR1 spectrum implies that Boltzmann weighting is
not valid for spectrum averaging of Otamixaban models. The equal
weighting of the conformer population in this study is based on
the spectrum ﬁtness measured by the maximal SV. We tried to
vary individual populations in the spectrum averaging, but no
Table 1 Calculated properties of VCD and x-ray conformers.
Conformer Energy (kcal/mol)a SI SV Ha–C–C–Hb torsion (deg) Calculated
3JHaHb (Hz) SASA
b (Å2)
RR1 0 0.61 0.09 66 5.7 728
RR2 1.93 0.57 0.18 77 5.1 688
RR5 5.00 0.56 0.30 73 5.3 695
RR10 12.73 0.76 0.26 69 5.5 696
RR13 13.50 0.73 0.33 68 5.6 690
xc 7.41 0.50 0.09 58 6.4 758
1KSN 6.77 0.65 0.08 54 6.7 725
aRelative to DFT energy 1486.42705 Hartree of RR1.
bSolvent accessible surface area as calculated with Maestro 8.5.
cModeled based on the intermediate 4 determined by scXRD in this study.
RR5RR2
RR10 RR13
XaRR1 
Fig. 5 The stick model of Otamixaban conformers. aModeled based on the intermediate 4 determined by scXRD in this study. Carbon, oxygen,
nitrogen and hydrogen atoms are colored in gray, red, blue and white, respectively. The green dash lines indicate the intramolecular H-bonds.
Non-polar hydrogens were removed for clarity.
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Table 2 IR frequencies of three bands at high wave number region (cm1).
Fundamental RR1 RR2 RR5 Experiment
143 1665 1660 1662 1653
144 1670 1669 1686 1686
145 1727 1733 1735 1732
Spectrum (red) Blue curves in the left panels
ppm123456789
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X= 
O
HN
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Fig. 6 1H NMR spectrum of Otamixaban in DMSO-d6. The chemical shifts of Ha and Hb are 3.01 ppm and 4.44 ppm, respectively. The coupling
constant 3JHaHb was determined with a varied amount of D2O as shown in the insert.
Vibrational circular dichroism of Otamixaban 203signiﬁcant improvement was achieved. This echoes the adjusted
population done by Zhang and Polavarapu [19]. They concluded
that the conformation averaging with DFT Gibbs energies weight-
ing simply cannot match the experimental results in DMSO-d6.
While the use of DFT energy for a conformer in non-polar solvents
may be a good approximation, polar solvents, such as DMSO and
water, interact strongly with a polar molecule thereby perturbing
its energies. In principle, the conformer energies calculated with
solvents should be more relevant in the conformer population
analysis. However, approaches using either implicit or explicit
solvents [20] in VCD calculations generated very limited successand have not been used widely, especially in industrial research
and development. Alternatively, our approach ignores the calcu-
lated energies and relies entirely on the compatibility of ﬁt
between the calculated and observed spectra, which is a quick
yet reliable solution.
Each solution conformer elucidated from the VCD should be
considered as a cluster of conformers with smaller structural
deviations. For example, the conformation space of the pyridinyl–
benzamide can have at least six local minimums by optimizing the
two torsions associated with the benzene ring. Because the small
variations (o1 Å RMSD) are not directly associated with the chiral
J. Shen et al.204centers, they do not cause signiﬁcant changes in the calculated VCD
spectra. Indeed, the differences of SV among the subset of RR5 are
less than 0.02.
Another structural variation investigated is the tautomerization
of the neutral amidine of Otamixaban. Although the amidine is not
near to the chiral centers, the energies as well as the spectra vary
signiﬁcantly for different tautomers (see SI). The current model,
e.g. RR5, gives a far better match in the spectrum comparison.
Therefore, the other tautomers were ignored.
As we demonstrated, VCD not only gives reliable AC of chiral
molecules but also provides rich information about solution struc-
tures. Despite many advantages of VCD, scXRD is usually the ﬁrst
option for AC determination. Besides less availability of high
performance VCD instrumentation, spectrum calculation and com-
parison for ﬂexible molecules are often challenging. For molecules
like Otamixaban, the number of conformers, including tautomers, can
exceed 200 with a ﬁner RMSD cutoff of 0.5 Å. Finding a set of SF
conformers (not necessarily the lower energy conformers) requires
both computing power and a good spectrum comparison algorithm.
As the technology improves, we expect more successful VCD
applications to be used for a wide range of chiral molecules. The
structures elucidated from VCD experiments will also help us to
better understand the solute energy landscape and to improve the
force ﬁelds and models in molecular modeling and simulations.4. Conclusion
With the aid of an automated spectrum comparison, the AC of
Otamixaban from the large scale synthesis has been unambigu-
ously determined to be (R,R) using VCD. Both visual examination
and spectrum similarity comparison indicate that the lowest energy
conformer is not populated in DMSO solution. The existence of
populated higher energy conformers is conﬁrmed by the char-
acteristic bands in observed and calculated IR spectra. The four
leading conformers elucidated in VCD adopt folded conformations
with smaller solvent accessible surface area, which differ from the
x-ray structures. The NMR study suggests that the conformation
difference is due to different solvation environments. For a sizable
and ﬂexible pharmaceutical molecule, the spectrum comparison
method SimIR/VCD can deliver a consistent performance in
ﬁnding the best matched spectra from the calculation.
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[18] E. Ōsawa, T. Ouchi, N. Saito, et al., Critical evaluation of an
empirically modiﬁed Karplus equation, Magn. Reson. Chem. 30
(1992) 1104–1110.
[19] P. Zhang, P.L. Polavarapu, Spectroscopic investigation of the
structures of dialkyl tartrates and their cyclodextrin complexes,
J. Phys. Chem. A 111 (2007) 858–871.
[20] V.P. Nicu, J. Neugebauer, E.J. Baerends, Effects of complex
formation on vibrational circular dichroism spectra, J. Phys. Chem.
A 112 (2008) 6978–6991.
